QLINE — Q-Line Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Q-Line Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	541	900	300	470	764
Net Total Accounts Receivable
Net Total Receivables	439	423	628	1,269	1,624
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,761	1,761	1,985	2,646	—
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	94	345	740	1,125	1,340
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,920	2,516	3,392	4,555	—
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	800	1,081	1,403	1,791	—
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	900	1,242	1,774	2,655	—
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	1,020	1,274	1,618	1,899	—
Total Liabilities & Shareholders' Equity	1,920	2,516	3,392	4,555	—
Total Common Shares Outstanding